These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9271444)

  • 1. Efficacy of monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired chronic mitral insufficiency.
    Kitagawa H; Wakamiya H; Kitoh K; Kuwahara Y; Ohba Y; Isaji M; Iwasaki T; Nakano M; Sasaki Y
    J Vet Med Sci; 1997 Jul; 59(7):513-20. PubMed ID: 9271444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
    Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation.
    Kvart C; Häggström J; Pedersen HD; Hansson K; Eriksson A; Järvinen AK; Tidholm A; Bsenko K; Ahlgren E; Ilves M; Ablad B; Falk T; Bjerkfås E; Gundler S; Lord P; Wegeland G; Adolfsson E; Corfitzen J
    J Vet Intern Med; 2002; 16(1):80-8. PubMed ID: 11822810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
    Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Ablad B; Bussadori CM; Glaus T; Kovacević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir AV; O'Sullivan ML; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
    J Vet Intern Med; 2008; 22(5):1124-35. PubMed ID: 18638016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.
    de Madron E; King JN; Strehlau G; White RV
    Can Vet J; 2011 Nov; 52(11):1219-25. PubMed ID: 22547843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: A retrospective study of 141 cases.
    Kittleson M; Rishniw M; Pion P; Kass P
    J Vet Intern Med; 2009; 23(5):953-4; author reply 955-6. PubMed ID: 19737176
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial.
    King JN; Hirakawa A; Sonobe J; Otaki H; Sakakibara N; Seewald W; Forster S
    J Vet Sci; 2018 Jan; 19(1):117-128. PubMed ID: 28693297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a retrospective study of 141 cases.
    Pouchelon JL; Jamet N; Gouni V; Tissier R; Serres F; Carlos Sampedrano C; Castaignet M; Lefebvre HP; Chetboul V
    J Vet Intern Med; 2008; 22(4):905-14. PubMed ID: 18482278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of mitral valve insufficiency in dogs with the ACE inhibitor enalapril. A clinical progress study].
    Biller B; Hörauf A; Kraft W
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 1998 Feb; 26(1):21-30. PubMed ID: 9531670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of an angiotensin-converting enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, after repeated administrations of benazepril in dogs with experimental kidney impairment.
    Kitagawa H; Eguchi T; Kitoh K; Ohba Y; Kondo M; Nakano M; Sasaki Y
    J Vet Med Sci; 2000 Feb; 62(2):179-85. PubMed ID: 10720188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the angiotensin-converting enzyme inhibitor alacepril in dogs with mitral valve disease.
    Hori Y; Nakamura K; Kanno N; Hitomi M; Yamashita Y; Hosaka S; Isayama N; Mimura T
    J Vet Med Sci; 2018 Aug; 80(8):1212-1218. PubMed ID: 29937457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency.
    Atkins CE; Keene BW; Brown WA; Coats JR; Crawford MA; DeFrancesco TC; Edwards NJ; Fox PR; Lehmkuhl LB; Luethy MW; Meurs KM; Petrie JP; Pipers FS; Rosenthal SL; Sidley JA; Straus JH
    J Am Vet Med Assoc; 2007 Oct; 231(7):1061-9. PubMed ID: 17916031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J; Lord PF; Höglund K; Ljungvall I; Jöns O; Kvart C; Hansson K
    J Vet Intern Med; 2013; 27(6):1452-62. PubMed ID: 24128373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The Benazepril Heart Failure Study Group.
    Colfer HT; Ribner HS; Gradman A; Hughes CV; Kapoor A; Laidlaw JC
    Am J Cardiol; 1992 Aug; 70(3):354-8. PubMed ID: 1632402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congestive heart failure due to bilateral atrioventricular valve insufficiency in two dogs.
    Takemura N; Koyama H; Motoyoshi S
    J Vet Med Sci; 1996 Apr; 58(4):381-4. PubMed ID: 8741276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
    Ettinger SJ; Benitz AM; Ericsson GF; Cifelli S; Jernigan AD; Longhofer SL; Trimboli W; Hanson PD
    J Am Vet Med Assoc; 1998 Dec; 213(11):1573-7. PubMed ID: 9838955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group.
    J Vet Intern Med; 1995; 9(4):234-42. PubMed ID: 8523320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of imidapril in congestive heart failure in dogs: results of the EFFIC study.
    Besche B; Chetboul V; Lachaud Lefay MP; Grandemange E
    J Small Anim Pract; 2007 May; 48(5):265-70. PubMed ID: 17472664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic therapy for congestive heart failure with benazepril HCl, a new angiotensin converting enzyme inhibitor.
    Mirvis DM; Insel J; Boland MJ; Cinquegrani MP; Ghali JK; Rubin SA; Shanes J; DeSilva J; Whalen JJ
    Am J Med Sci; 1990 Dec; 300(6):354-60. PubMed ID: 2264573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
    Thomason JD; Rockwell JE; Fallaw TK; Calvert CA
    J Vet Cardiol; 2007 Nov; 9(2):103-8. PubMed ID: 17983885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.